(Q45861347)

17 December 2017

title

Vector-based RNAi, a novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancer (English)

1 reference

17 December 2017

0 references

Lin Zhang

1

1 reference

17 December 2017

Nuo Yang

2

1 reference

17 December 2017

Alisha Mohamed-Hadley

3

1 reference

17 December 2017

Stephen C Rubin

4

1 reference

17 December 2017

George Coukos

5

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

17 December 2017

Biochemical and Biophysical Research Communications

published in

1 reference

17 December 2017

volume

303

1 reference

17 December 2017

issue

4

1 reference

17 December 2017

page(s)

1169-1178

1 reference

17 December 2017

Angiogenesis in cancer and other diseases

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Comparative expression of novel vascular endothelial growth factor/vascular permeability factor transcripts in skin, papillomas, and carcinomas of v-Ha-ras Tg.AC transgenic mice and FVB/N mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Differential expression of VEGF isoforms in mouse during development and in the adult

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Expression pattern of vascular endothelial growth factor isoform is closely correlated with tumour stage and vascularisation in renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Isoforms of vascular endothelial growth factor act in a coordinate fashion To recruit and expand tumor vasculature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

VEGF-Trap: a VEGF blocker with potent antitumor effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Gene silencing in mammals by small interfering RNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Analysis of gene function in somatic mammalian cells using small interfering RNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Mammalian RNAi for the masses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

siRNA-directed inhibition of HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Stable suppression of tumorigenicity by virus-mediated RNA interference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

A DNA vector-based RNAi technology to suppress gene expression in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

A system for stable expression of short interfering RNAs in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Effective expression of small interfering RNA in human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

U6 promoter-driven siRNAs with four uridine 3' overhangs efficiently suppress targeted gene expression in mammalian cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Gene silencing using micro-RNA designed hairpins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Development of a syngeneic mouse model for events related to ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Different effects of glucose starvation on expression and stability of VEGF mRNA isoforms in murine ovarian cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Expanding small RNA interference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Stable suppression of gene expression by RNAi in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Retroviral vectors designed for targeted expression of RNA polymerase III-driven transcripts: a comparative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Small interfering RNA and gene silencing in transgenic mice and rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

Effects on RNA interference in gene expression (RNAi) in cultured mammalian cells of mismatches and the introduction of chemical modifications at the 3'-ends of siRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900495-9

10.1016/S0006-291X(03)00495-9

7 January 2021

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017